FibroGen Inc header image

FibroGen Inc

FGEN

Equity

ISIN null / Valor 25953994

NASDAQ (2026-10-09)
USD 6.11+2.52%

FibroGen Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

FibroGen is a biopharmaceutical company that discovers, develops and commercializes therapies focused primarily on anemia, fibrotic diseases and oncology; its most advanced programs include an oral hypoxia‑inducible factor (HIF) prolyl hydroxylase inhibitor for anemia associated with chronic kidney disease and an anti‑connective tissue growth factor (CTGF) antibody being developed for fibrotic disorders and select cancers. The company advances candidates through clinical trials, leverages partnerships with larger pharmaceutical companies for development and global commercialization, and generates revenue through product sales, milestone and royalty arrangements, and collaborative agreements while maintaining a pipeline of earlier‑stage programs aimed at addressing unmet needs in hematology, fibrosis and oncology.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-44.3%1Y
-66.1%3Y
-97.7%5Y

Performance

51.8%1Y
112%3Y
126%5Y

Volatility

Market cap

25 M

Market cap (USD)

Daily traded volume (Shares)

6,566

Daily traded volume (Shares)

1 day high/low

0.59 / 0.5133

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.69%SEK 263.70
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%USD 196.93
CVS Group PLC
CVS Group PLC CVS Group PLC Valor: 3457960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%GBP 11.73
Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%USD 3.54
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%GBP 2.47
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%INR 801.05
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.69%INR 1,719.55
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.45%USD 17.59
Sienna Senior Living Inc
Sienna Senior Living Inc Sienna Senior Living Inc Valor: 28093100
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%CAD 19.29
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.16%DKK 341.20